TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,326 | -66.4% | 17,862 | -0.3% | 0.00% | -66.7% |
| Q2 2023 | $444,835 | +65.6% | 17,908 | +0.3% | 0.01% | +50.0% |
| Q1 2023 | $268,644 | +27.1% | 17,862 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $211,307 | +99.3% | 17,862 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $106,000 | +39.5% | 17,862 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $76,000 | – | 17,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |